Evidence map›Paper›PMID 20040865›Full record

ReviewCurrent opinion in gastroenterology2010

Microbial influences on the small intestinal response to radiation injury.

Christopher D Packey, Matthew A Ciorba

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Current opinion in gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01790035 phase1terminatednot on this mapstarted 2014, after this paper: background citation

A Phase I and Randomized Controlled Phase II Trial of the Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer

TypeinterventionalSponsorWashington University School of MedicineRan2014 to 2021Enrolled23ConditionsGastrointestinal NeoplasmsArmsLGG, Placebo
NCT01849107 nacompletednot on this mapstarted 2013, after this paper: background citation

Plasma Citrulline: A Marker for Monitoring & Quantifying Radiation-Induced Small Bowel Toxicity

TypeinterventionalSponsorAsan Medical CenterRan2013 to 2014Enrolled49ConditionsDiarrhea, Anorexia, DyspepsiaArmsPlasma citrulline
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Contemporary oncology (Poznan, Poland) · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Gut · 2019
    Article
  17. Article
  18. Probiotics and Colon Cancer.Microorganisms · 2019
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Christopher D PackeyDivision of Gastroenterology, Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, USA.
Matthew A Ciorba
University of North Carolina at Chapel Hill · USWashington University in St. Louis · US

Funding

GASTROENTEROLOGY RESEARCH TRAININGT32DK007737 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SHEHZAD Z. SHEIKH · 1996 to 2026
$7.8M
NCRR NIH HHS L30 RR030244NIDDK NIH HHS T32 DK007737NIDDK NIH HHS T-32 DK07737
6 · The paper itself

Abstract

purpose of reviewInjury to the small bowel from ionizing radiation occurs commonly in patients undergoing cancer therapy and less commonly in instances of accidental radiation overexposure. Several lines of evidence now suggest that dynamic interactions between the host's enteric microbiota and innate immune system are important in modulating the intestinal response to radiation. Here, we will review recent developments in the area of acute radiation enteropathy and examine the current state of knowledge regarding the impact of host-microbial interactions in the process. RECENT

findingsThere is promise in the development and testing of new clinical biomarkers including serum citrulline. Toll-like receptor agonists and innate immune system signaling pathways including nuclear factor-kappa B profoundly alter intestinal epithelial cell apoptosis and crypt survival after radiation exposure. Germ-free conditions, probiotics and antibiotics are each identified as modifiers of disease development and course. A human study suggested that luminal microbiota composition may influence the host's intestinal response to radiation and may change in those developing postradiation diarrhea. SUMMARY: New knowledge implies that investigations aimed at deciphering the microbiome-host interactions before and after small bowl radiation injury may eventually allow prediction of disease course and offer opportunities for the development of novel therapeutic or prophylactic strategies.

Indexed as

Anti-Bacterial AgentsFemaleHumansIntestinal DiseasesIntestine, SmallMaleMetagenomeMicrobial InteractionsProbioticsPrognosisRadiation InjuriesRisk AssessmentTreatment OutcomeAnti-Bacterial Agents

Identifiers

PMID20040865
PMCPMC4063200
OpenAlexW1994138288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.